Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies
JAMA Neurol 72:874-881,861, Arino, H.,et al, 2015
Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia
Clin Lymphoma Myeloma Leuk 12:164-179, Lopes da Silva, R., 2012
Spectrum of Neurological Syndromes Associated with Glutamic Acid Decarboxylase Antibodes: Diagnostic Clues for this Association
Brain 131:2553-2563, Saiz,A., et al, 2008
Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008
Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes
JNNP 75:1135-1140,1090, Graus,F.,et al, 2004
Glutamic Acid Decarboxylase Autoantibodies and Neurological Disorders
Neurol Sci 23:145-151, Vianello,M.,et al, 2002
Calcium Channels in Neurological Disease
Ann Neurol 42:275-282, Greenberg,D.A., 1997
Guidelines on the Detection of Paraneoplastic Anti-Neuronal-Specific Antibodies
Neurol 45:1937-1941, Moll,J.W.B.,et al, 1995
The Spectrum of Neurological Disease in Patients with Systemic Cancer
Ann Neurol 31:268-273, Clouston,P.D.,et al, 1992
Immunologic Aspects of Neurological and Neuromuscular Diseases
JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992
Diagnostic Value of Anti-Neuronal Antibodies for Paraneoplastic Disorders of the Nervous System
JNNP 53:940-943, Moll,J.W.B.,et al, 1990